If the screening test was available now this would be Many multiples. efficacy? Unknown. however it is the reason for a CR - to develop the requirements to achieve the intended results. What is promising is the 1.2 CR.
- Forums
- ASX - By Stock
- GTG
- News: GTG Genetic Technologies Files Provisional Patent For Its COVID-19 Severity Risk Test With...
News: GTG Genetic Technologies Files Provisional Patent For Its COVID-19 Severity Risk Test With..., page-47
Featured News
Add GTG (ASX) to my watchlist
|
|||||
Last
4.3¢ |
Change
0.003(7.50%) |
Mkt cap ! $6.252M |
Open | High | Low | Value | Volume |
4.0¢ | 4.3¢ | 4.0¢ | $4.295K | 100.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 71949 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 2722 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 71949 | 0.040 |
1 | 20000 | 0.039 |
5 | 143982 | 0.038 |
4 | 86054 | 0.037 |
1 | 13152 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 2722 | 1 |
0.044 | 99910 | 1 |
0.045 | 23772 | 2 |
0.046 | 8556 | 1 |
0.047 | 11800 | 1 |
Last trade - 12.43pm 11/09/2024 (20 minute delay) ? |
Featured News
GTG (ASX) Chart |